T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity
表达高效 PRAME 特异性 T 细胞受体的 T 细胞与嵌合 PD1-41BB 共刺激受体结合，表现出良好的临床前安全性和强大的抗肿瘤反应性
期刊:Cancers
影响因子:
doi:10.3390/cancers14081998
Nadja Sailer, Ina Fetzer, Melanie Salvermoser, Monika Braun, Doris Brechtefeld, Christian Krendl, Christiane Geiger, Kathrin Mutze, Elfriede Noessner, Dolores J Schendel, Maja Bürdek, Susanne Wilde, Daniel Sommermeyer
